Skip to content

Early VItrectomy in DENse Spontaneous Vitreous HEmorrhage

Comparaison de la Vitrectomie précoce et de la Surveillance Simple Dans la Prise en Charge Des hémorragies du vitré spontanées EVIDENSE Early VItrectomy in DENse Spontaneous Vitreous HEmorrhage

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04676256
Acronym
EVIDENSE
Enrollment
8
Registered
2020-12-21
Start date
2021-07-02
Completion date
2024-06-27
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Break, Retinal Detachment, Spontaneous Vitreous Hemorrhage

Keywords

spontaneous vitreous hemorrhage, retinal break, retinal detachment, ultrasound, vitrectomy

Brief summary

The aim of the protocol is to compare the ocular outcomes after spontaneous vitreous hemorrhage treated with an early vitrectomy versus ultrasound monitoring with late vitrectomy. The hypothesis is that an early vitrectomy could decrease the rate of retinal detachment occurring after a spontaneous vitreous hemorrhage.

Detailed description

The aim of the protocol is to compare the ocular outcomes after spontaneous vitreous hemorrhage treated with an early vitrectomy versus ultrasound monitoring with late vitrectomy. The hypothesis is that an early vitrectomy could decrease the rate of retinal detachment occurring after a spontaneous vitreous hemorrhage. Scientific background Spontaneous vitreous hemorrhage may occur after spontaneous posterior vitreous detachment and causes retinal break and retinal detachment in about 70% and 40% of cases respectively. The fundus examination and ultrasound have limited sensitivity to detect retinal breaks in these cases. Some retrospective studies have highlighted the benefit of an early vitrectomy for decreasing the rate of visual loss due to retinal detachment in these cases. However, to date, there is no national or international consensus regarding the management of spontaneous vitreous hemorrhage and the timing of vitrectomy. Study design Prospective randomized clinical trial Primary objective To compare the results of an early vitrectomy versus ultrasound and fundus observation in spontaneous vitreous hemorrhage. Secondary objectives To evaluate the rate of retinal complications in spontaneous vitreous hemorrhage treated either with early or delayed vitrectomy. To evaluate the rate of visual loss in spontaneous vitreous hemorrhage treated either with early or delayed vitrectomy. Primary criteria Rate of retinal detachment in eyes with spontaneous vitreous hemorrhage treated with early vitrectomy versus ultrasound observation at 6-month follow-up Secondary criteria Rate of retinal breaks and vitreo-retinal proliferation in eyes with spontaneous vitreous hemorrhage treated with early vitrectomy versus ultrasound observation at 6-month follow-up Visual acuity and rate of eyes with a loss of 5 letters or more among eyes with spontaneous vitreous hemorrhage treated with early vitrectomy versus ultrasound observation at 6-month follow-up Participants Patients with a spontaneous vitreous hemorrhage secondary to posterior vitreous detachment, with a reduced visibility of the fundus Inclusion criteria * Age \> or = 18 years old * Spontaneous vitreous hemorrhage which is 1/ secondary to posterior vitreous detachment; 2/ acute: which duration is \< 15 days, 3/ dense: reduced visibility of the fundus Exclusion criteria: * Retinal detachment at the initial examination * Any history of vascular retinal disease (diabetic retinopathy, retinal vein occlusion…) * Any history of uveitis, age-related macular degeneration * History of a recent ocular traumatism (\< 3 months) * History of a recent retinal laser treatment (\< 3 months) or vitreo-retinal surgery (\< 3 months) * Absence of consent Experimental group Eyes with spontaneous vitreous hemorrhage treated with early vitrectomy (n = 63) Active Comparator group Eyes with spontaneous vitreous hemorrhage only observed using fundus examination and B-ultrasound (n = 63) Study duration Inclusion: 12 months Participation: 6 months Total duration: 18 months

Interventions

Eyes with spontaneous vitreous hemorrhage treated with early vitrectomy (n = 63)

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> or = 18 years old * Spontaneous vitreous hemorrhage which is : 1. secondary to posterior vitreous detachment; 2. acute: which duration is \< 15 days, 3. dense: reduced visibility of the fundus

Exclusion criteria

* Retinal detachment at the initial examination * Any history of vascular retinal disease (diabetic retinopathy, retinal vein occlusion…) * Any history of uveitis, age-related macular degeneration * History of a recent ocular traumatism (\< 3 months) * History of a recent retinal laser treatment (\< 3 months) or vitreo-retinal surgery (\< 3 months) * Absence of oral and written consent

Design outcomes

Primary

MeasureTime frameDescription
Rate of retinal detachment6 months after interventionnumber of eyes with a retinal detachment in each group. The presence of retinal detachment will be assessed on fundus examination

Secondary

MeasureTime frameDescription
Rate of retinal breaks6 months after interventionnumber of eyes with a retinal breaks in each group. The presence of retinal breaks will be assessed on fundus examination
Rate vitreo-retinal proliferation6 months after interventionnumber of eyes with a vitreo-retinal proliferation in each group. The presence of vitreo-retinal proliferation will be assessed on fundus examination
Visual acuity6 months after interventionvisual acuity will be measured using Snellen and/or ETDRS chart
Rate of eyes with a loss of 5 letters or more6 months after intervention
Rate of cataract6 months after intervention

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026